跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Etiriz - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Etiriz
Approved
STANDARD
Etiriz
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f5886d10655bda61
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
f5886d10655bda61
Drug Approval Philippines Name
Etiriz
Product Name
Etiriz
Registration Number
DRP-920-04
Brand Name
Etiriz
Generic Name
Cetirizine Dihydrochloride
Dosage Form
Film-Coated Tablet
Dosage Strength
10mg
Manufacturer
Lloyd Laboratories, Inc.
Trader
Eurohealthcare Exponents, Inc.
Distributor
Medirich Pharma Distribution Corp.
Issuance Date
25 February 2022
Expiry Date
14 March 2027
Pharmacologic Category
Antihistamine (H1 Receptor Antagonist)
Classification
Over-The-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f5886d10655bda61
Type
Standard
Back to Philippines FDA Approvals